4//SEC Filing
BAILES JOSEPH S 4
Accession 0001209191-22-039322
CIK 0001708493other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 6:41 PM ET
Size
8.1 KB
Accession
0001209191-22-039322
Insider Transaction Report
Form 4
BAILES JOSEPH S
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2022-06-22$1.40/sh+31,428$43,999→ 31,428 totalExercise: $2.01Exp: 2032-06-21→ Common Stock (31,428 underlying) - Award
Director Stock Option (Right to Buy)
2022-06-22+10,167→ 10,167 totalExercise: $2.01Exp: 2032-06-21→ Common Stock (10,167 underlying)
Footnotes (3)
- [F1]The stock option will fully vest and become exercisable on June 21, 2023, subject to the continuous service of the Reporting Person with the Issuer on such date.
- [F2]This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $44,000 ("Election Option").
- [F3]One-half of the Election Option vested and became exercisable on June 22, 2022, and 25% of each Election Option will vest and become exercisable on each of September 30, 2022 and December 31, 2022, subject to the continuous service of the Reporting Person with the Issuer through each vesting date.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
Related Parties
1- filerCIK 0001201039
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 6:41 PM ET
- Size
- 8.1 KB